1 |
Arikawa, T., Omura, K. and Morita, I. (2004). Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J. Cell Physiol. 200, 400-406.
DOI
|
2 |
Borglum, J. D., Pedersen, S. B., Ailhaud, G., Negrel, R. and Richelsen, B. (1999). Differential expression of prostaglandin receptor mRNAs during adipose cell differentiation. Prostaglandins and other Lipid Mediat. 57, 305-317.
DOI
|
3 |
Entenmann, G. and Hauer, H. (1996). Relationship between replication and differentiation in cultured human adipocyte precursor cells. Am. J. Physiol. 270, C1011-C1016.
DOI
|
4 |
Gregoire, F. M., Smas, C. M. and Sul, H. S. (1998). Understanding adipocyte differentiation. Physiol. Rev. 78, 783-809.
DOI
|
5 |
Hazra, S., Batra, R. K., Tai, H. H., Sharma, S., Cui, X. and Dubinett, S. M. (2007). Pioglitazone and rosiglitazone decreases prostaglandin in non-small-cell lung cancer cells by up-regulating 15-hydroxysprostaglandin dehydrogenase. Mol. Pharmacol. 71, 1715-1720.
DOI
|
6 |
He, G., Sung, Y. M. and Fischer, S. M. (1996). Troglitazone induction of COX-2 expression is dependent on ERK activation in keratinocytes. Prostaglandins Leukotrienes Essent. Fatty Acids 74, 193-197.
|
7 |
Inoue, H., Tanabe, T. and Umesono, K. (2000). Feedback control of cyclooxygenase-2 expression through PPARgamma. J. Biol. Chem. 275, 28028-28032.
|
8 |
Janderova, L., McNeil, M., Murrell, A. N., Mynatt, R. L. and Smith, S. R. (2003). Human mesenchymal stem cells as an in vitro model for human adipogenesis. Obesity Res. 11, 65-74.
DOI
|
9 |
Murakami, M., Nakashima, K., Kamei, D., Masuda, S., Ishikawa, Y., Ishii, T., Ohmiya, Y., Watanabe, K. and Kudo, I. (2003). Cellular prostaglandin E2 production by membrane-bound prostaglandin E synthase-2 via both cyclooxygenases-1 and -2. J. Biol. Chem. 278, 37937-37947.
DOI
|
10 |
Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S. and Marshak, D. R. (1999). Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147.
DOI
|
11 |
Reginato, M. J., Krakow, S. L., Bailey, S. T. and Lazar, M. A. (1998). Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma. J. Biol. Chem. 273, 1855-1858.
DOI
|
12 |
Shin, J. H., Shin, D. W. and Noh, M. (2009b). IL-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes. Biochem. Pharmacol. 77, 1835-1844.
DOI
|
13 |
Rosen, E. D. (2005). The transcriptional basis of adipocyte development. Prostaglandins Leukotrienes Essent. Fatty Acids 73, 31-34.
DOI
|
14 |
Sakaguchi, Y., Sekiya, I., Yagishita, K. and Takeshi, M. (2005). Comparison of human stem cells derived from various mesenchymal tissues. Arthritis Rheum. 52, 2521-2529.
DOI
|
15 |
Shin, D. W., Kim, S. N., Lee, S. M., Lee, W., Song, M. J., Park, S. M., Lee, T. R., Baik, J. H., Kim, H. K., Hong, J. H. and Noh, M. (2009a). (-)-Catechin promotes adipocyte differentiation in human bone marrow mesenchymal stem cells through PPARgamma transactivation. Biochem. Pharmacol. 77, 125-133.
DOI
|
16 |
Braithwaite, S. S. and Jarabak, J. (1975). Studies on a 15-hydroxyprostaglandin dehydrogenase from human placenta. J. Biol. Chem. 250, 2315-2318.
|
17 |
Chou, W. L., Chuang, L. M., Chou, C. C., Wang, A. H., Lawson, J. A., FitzGerald, G. A. and Chang, Z. F. (2007). Identification of a novel prostaglandin reductase reveals the involvement of prostaglandin E2 catabolism in regulation of peroxisome proliferator-activated receptor gamma activation. J. Biol. Chem. 282, 18162-18172.
DOI
|
18 |
Xie, Y., Kang, X., Ackerman, W. E., Belury, M. A., Koster, C., Rovin, B. H., Landon, M. B. and Kniss, D. A. (2006). Differentiation-dependent regulation of the cyclooxygenase cascade during adipogenesis suggests a complex role for prostaglandins. Diabetes Obesity Metab. 8, 83-93.
DOI
|
19 |
Yang, W. L. and Frucht, H. (2001). Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells. Carcinogenesis 22, 1379-1383.
DOI
|
20 |
Yan, H., Kermouni, A., Abdel-Hafez, M. and Lau, D. C. W. (2003). Role of cyclooxygenases COX-1 and COX-2 in modulating adipogenesis in 3T3-L1 cells. J. Lipid Res. 44, 424-429.
DOI
|
21 |
Murakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., Ikeda, T., Fueki, M., Ueno, A., Ohishi, S. and Kudo, I. (2000). Regulation of Prostaglandin E2 Biosynthesis by Inducible Membrane-associated Prostaglandin E2 Synthase That Acts in Concert with Cyclooxygenase-2. J. Biol. Chem. 275, 32783-32792.
DOI
|
22 |
Pfaffl. M. W. (2001). A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45.
DOI
ScienceOn
|
23 |
Tsuboi, H., Sugimoto, Y., Kainoh, T. and Ichikawa, A. (2004). Prostanoid EP4 receptor is involved in suppression of 3T3-L1 adipocyte differentiation. Biochem. Biophys. Res. Comm. 322, 1066-1072.
DOI
|
24 |
Tanikawa, N., Ohmiya, Y., Ohkubo, H., Hashimoto, K., Kangawa, K., Kojima, M., Ito, S. and Watanabe, K. (2002). Identification and characterization of a novel type of membrane-associated prostaglandin E synthase. Biochem. Biophys. Res. Comm. 291, 884-889.
DOI
|